Experimental One-Dose Treatment Cuts 'Bad' Cholesterol by 52% in First Human Trial | ScienceAlert
NEW9 days ago|Discuss (0)|Science
Article written by David Nield
A new DNA-editing treatment called CTX310 has shown promise in significantly reducing 'bad' cholesterol levels in patients during its first human trial. Conducted by researchers at the Cleveland Clinic, the study indicates the treatment could offer a long-term solution for individuals with specific lipid disorders.
Read full story @ www.sciencealert.com/experimental-one-dose-treatment-cuts-bad-cholesterol-by-52-in-first-human-trial »
NewzGrade: 88 [B+]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
88B+
FDCBA
SPAG90
Coherent85
Objective95
Sourced90
Concise80
Graded by NewzGrade AI AI · provisional on September 04, 2026 at 02:22 PM
88B+
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 90 | 85 | 95 | 90 | 80 |
88B+grade breakdown
SPAG
90
Coherent
85
Objective
95
Sourced
90
Concise
80
The article effectively presents scientific findings in a balanced manner, adhering to journalistic standards for news reporting. The details on the trial's outcomes and methodologies provide a clear understanding of the research's significance.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
